You have no items in your shopping cart.

Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law

Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law

  • Author:
  • Publisher: Kluwer Law International
  • ISBN: 9789403501130
  • Published In: August 2018
  • Format: Hardback
  • Jurisdiction: International ? Disclaimer:
    Countri(es) stated herein are used as reference only

List Price: HKD 1,930.00

HKD 1,814.20 Save HKD 115.80 (6%)

Delivery Time: around 2 weeks
Extra 2-10 working days working days if shipping address outside Hong Kong
Free delivery HK & China?
Hong Kong: free delivery (order over HKD 500)
China: free delivery (order over RMB 500)
OR
  • Description 
  • Contents 
  • Details

    Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law examines patent settlements between originators and generic pharmaceutical manufacturers under United States (US) antitrust and European Union (EU) competition law. The major focus is on patent settlements involving reverse payments, commonly known as “pay-for-delay” settlements. Reverse payment settlements or “pay-for-delay agreements” create heated debates regarding the balance between competition and intellectual property law. These settlements touch upon sensitive issues such as timely generic entry and access to affordable pharmaceuticals on the one hand and the need to preserve innovation incentives for originators and to strengthen the pipeline of life-saving pharmaceuticals on the other hand. This book is one of the first to analyse critically and comparatively how such patent settlements and various other strategies employed by the pharmaceutical industry are scrutinised by US and European courts as well as enforcement authorities, focusing on the applicable legal tests and the main criteria used by courts and enforcement authorities when applying antitrust scrutiny.

    What’s in this book:

    The book’s ultimate objective is to provide guidance to the pharmaceutical industry regarding the types of patent settlements, strategies and conduct which may be problematic from US antitrust and EU competition law perspectives and to assist practitioners in structuring settlements which are both efficient and compliant. To this end, an exhaustive legal analysis of some of the most controversial issues regarding pharmaceutical patent settlements is provided, including:

    • the lengthy split among US Circuit Courts on the issue of pay-for-delay settlements, its resolution by the US Supreme Court in FTC v. Actavis and subsequent jurisprudence;
    • the decision of Lundbeck v. Commission by the European General Court and the Servier decision of the European Commission;
    • the Roche/Novartis decision of the European Court of Justice and the most important decisions by National Competition Authorities on pharma patent settlements in the EU;
    • an overview of other types of strategies such as product-hopping and product reformulations, no-authorised generic commitments, problematic side-deals and mechanisms affecting generic substitution;
    • the rejection of the “scope of the patent” test in both the US and the EU and the balancing  of patent law and antitrust law considerations in the prevailing applicable tests;
    • the benefits of settlements and the main criteria for assessing their legitimacy under US antitrust and EU competition law.

    The analysis provides concrete examples of both illegitimate and legitimate settlements and strategies, emphasising on conduct that falls within a grey zone and on the circumstances and criteria under which such conduct could be deemed problematic from an antitrust perspective. This book argues that even though patent settlements and other types of potentially exclusionary and abusive conduct change form rapidly, the main criteria for their assessment remain broadly the same.

    How this will help you:

    This book will serve as a valuable guide for pharmaceutical companies wishing to minimise the risk of engaging in conduct that could potentially infringe US antitrust and EU competition law. This book is also beneficial to legal counsels, practicing attorneys, competition authorities and judges wishing to have the overview of the current legal standards in both the US and the EU. It further aims to save courts and enforcement agencies and also practitioners and academics considerable time and resources by providing an exhaustive analysis of the relevant case law, with the ultimate goal to increase legal certainty on the most controversial aspects of patent settlements in the pharmaceutical industry.

  • Preface

    List of Abbreviations

    Acknowledgements

    Introduction

    PART I
    Pharma Innovation and Settlements

    CHAPTER 1
    Pharma R&D and Settlements

    PART II
    Pharma Settlements in the US

    CHAPTER 2
    The US Regulatory Framework

    CHAPTER 3
    The US Circuits’ Split on Reverse Payment Settlements

    CHAPTER 4
    FTC v. Actavis

    PART III
    Pharma Settlements in the EU

    CHAPTER 5
    The European Regulatory Framework

    CHAPTER 6
    Delaying Generic Entry in the EU

    Conclusion

    Bibliography

    Table of Cases

    Tables of Statutes & Legislation

    Index

You may also be interested in these books:

Hong Kong Employment Law: A Practical Guide, 5th Edition
Hong Kong Employment Law: A Practical Guide, 5th Edition

List Price: HKD 1,500.00

HKD 1,410.00 Save HKD 90.00 (6%)

Building Management in Hong Kong, 3rd Edition
Building Management in Hong Kong, 3rd Edition

List Price: HKD 1,600.00

HKD 1,200.00 Save HKD 400.00 (25%)

Hong Kong Listed Company: Law and Practice
Hong Kong Listed Company: Law and Practice

List Price: HKD 1,980.00

HKD 1,861.20 Save HKD 118.80 (6%)

Commercial Litigation in Hong Kong: A Practical Guide, 2nd Edition
Commercial Litigation in Hong Kong: A Practical Guide, 2nd Edition

List Price: HKD 3,288.00

HKD 3,090.72 Save HKD 197.28 (6%)

Butterworths Hong Kong Company Law (Winding-Up and Miscellaneous Provisions) Handbook, 3rd Edition
Butterworths Hong Kong Company Law (Winding-Up and Miscellaneous Provisions) Handbook, 3rd Edition

List Price: HKD 1,300.00

HKD 1,222.00 Save HKD 78.00 (6%)

Doing Business in China: A Quick Tax Guide
Doing Business in China: A Quick Tax Guide

List Price: HKD 600.00

HKD 564.00 Save HKD 36.00 (6%)

Negotiated Acquisitions and Buyouts
Negotiated Acquisitions and Buyouts

List Price: HKD 730.00

HKD 686.20 Save HKD 43.80 (6%)

Hong Kong Company Secretary Checklist
Hong Kong Company Secretary Checklist

List Price: HKD 788.00

HKD 740.72 Save HKD 47.28 (6%)

Hong Kong IPO: A Practical Guide, 2nd Edition
Hong Kong IPO: A Practical Guide, 2nd Edition

List Price: HKD 1,980.00

HKD 1,861.20 Save HKD 118.80 (6%)

Concise Guide: Compliance and Company Secretarial Practice of Hong Kong Private Companies
Concise Guide: Compliance and Company Secretarial Practice of Hong Kong Private Companies

List Price: HKD 2,388.00

HKD 2,244.72 Save HKD 143.28 (6%)

Hong Kong Company Law, 14th Edition
Hong Kong Company Law, 14th Edition

List Price: HKD 489.00

HKD 459.66 Save HKD 29.34 (6%)

Individual Income Tax Planning for Expatriates in China, 6th Edition
Individual Income Tax Planning for Expatriates in China, 6th Edition

List Price: HKD 1,280.00

HKD 1,203.20 Save HKD 76.80 (6%)